相关实验视频
Updated: May 30, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.4K
CA-SQBG:交叉注意力引导的语量子BIGRU用于药物相互作用提取
Ting Zhang1, Changqing Yu1, Shanwen Zhang1
1College of Electronic Information, Xijing University, Xi'an, China.
Computers in biology and medicine
|January 26, 2025
概括
这项研究引入了一种用于药物相互作用提取的新型量子深度学习模型,提高了药物监测的准确性和效率. 新方法有效地捕捉复杂的药物关系,优于现有技术.
科学领域:
- 计算生物学是一种计算生物学.
- 量子计算是一种量子计算.
- 自然语言处理自然语言处理.
背景情况:
- 准确的药物相互作用提取 (DDIE) 对于药物监测和药物开发至关重要.
- 现有的方法在不平衡的数据集和有限的手动注释方面扎.
研究的目的:
- 为改进DDIE开发一个先进的模型.
- 为了增强药物对的特征表示学习.
主要方法:
- 开发了一个交叉注意力引导的姆量子BiGRU (CA-SQBG) 模型.
- 利用变量量子环境和四代数来提取特征.
- 员工交叉注意力,以实现协作DDI提取.
主要成果:
- CA-SQBG有效地捕捉到多式联运特征中的相互和内部依赖关系.
- 与最先进的DDIE方法相比,该模型实现了卓越的性能.
- 用少数参数和有限的训练样本证明了有效性.
结论:
- CA-SQBG为准确和高效的DDIE提供了一个有前途的方法.
- 突出了量子计算和姆网络在DDIE中的潜力.
- 开发的模型可以显著帮助药物监测和药物开发工作.
关键词:
交叉注意力引导的姆QBiGRU (CA-SQBG) 进行了交叉注意力引导.提取DDI (DDIE) 的方法药物相互作用 (DDI) 是一种药物相互作用.量子比格鲁 (QBiGRU) 是一个量子比格鲁.更多相关视频
相关概念视频
Quantitative Aspects of Drug-Receptor Interaction
931
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
931
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Drug-Receptor Interactions
4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K
Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
Drug-Receptor Interaction: Antagonist
2.7K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.7K
Combined Effects of Drugs: Antagonism
8.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.2K

